Moneycontrol
SENSEX NIFTY

GlaxoSmithKline Pharmaceuticals Ltd.

BSE: 500660 | NSE: GLAXO | ISIN: INE159A01016 | SECTOR: PHARMACEUTICALS |
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Dec 13, 16:00
2419.20
-23.80 (-0.97%)
VOLUME 1,172
AVERAGE VOLUME
5-Day 1,159
10-Day 1,041
30-Day 1,101
VOLUME SHOCKER
5-Day 1,159
10-Day 1,041
30-Day 1,101
Prev. Close
2443.00
Open Price
2442.00
Bid PRICE (QTY.)
2411.00 (5)
Offer PRICE (Qty.)
2419.20 (52)
VWAP 2434.14
Market
Depth

Market Depth (14 Dec 2017)

BUY SELL
QTY PRICE PRICE QTY
2 2412.05 2416.00 2
25 2412.00 2418.00 5
1 2411.05 2422.00 3
5 2411.00 2422.10 2
100 2408.00 2423.00 5
453 Total 184 Total

Buy Qty

453

Sell QTY

184

Today's Low/High 2411.05 2469.20
52 Wk Low/High 2309.05 2795.00
L/U Price Band 1,954.40 2,931.60
LIVE
NSE
Dec 13, 15:54
2419.00
-22.05 (-0.90%)
VOLUME 9,160
AVERAGE VOLUME
5-Day 8,391
10-Day 8,260
30-Day 9,170
VOLUME SHOCKER
5-Day 8,391
10-Day 8,260
30-Day 9,170
Prev. Close
2441.05
Open Price
2441.00
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
2419.00 (52)
VWAP 2426.46
Today's Low/High 2401.50 2444.75
52 Wk Low/High 2201.20 3323.00
L/U Price Band 1,952.85 2,929.25
Action in GlaxoSmithKline Pharmaceuticals

No recommendations so far.

What's your call on GlaxoSmithKline today?
Read 2 investor views

Consolidated
MARKET CAP (Rs Cr)
20,491.35
P/E
-
BOOK VALUE (Rs)
236.93
DIV (%)
500.00%
Market Lot
1
INDUSTRY P/E
29.39
EPS (TTM)
* -
P/C
-
PRICE/BOOK
10.21
DIV YIELD.(%)
2.07%
FACE VALUE (Rs)
10.00
DELIVERABLES (%)
58.86 new
DELIVERY AVERAGES
3-Day 67.20%
5-Day 62.01%
8-Day 61.48%
* Note - Trailing EPS is displayed only when latest 4 quarter results are available.
Track GlaxoSmithKline on the go with the moneycontrol app
Also available for
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

21 November 2017

buy

BajajFinance Nov Fut

Entry Price (Rs)

1,792.00

Exit Price (Rs)

1,822.00

Gain (Rs)

30.00

buy

TataSteel Nov Fut

Entry Price (Rs)

701.20

Exit Price (Rs)

712.00

Gain (Rs)

11.00

buy

TitanCompany Nov Fut

Entry Price (Rs)

803.40

Exit Price (Rs)

810.20

Gain (Rs)

7.00

buy

Wockhardt Nov Fut

Entry Price (Rs)

732.80

Exit Price (Rs)

748.00

Gain (Rs)

15.00

buy

DATAM GLOB Nov Fut

Entry Price (Rs)

128.40

Exit Price (Rs)

135.50

Gain (Rs)

8.00

buy

MaxFinancial Nov Fut

Entry Price (Rs)

570.00

Exit Price (Rs)

580.50

Gain (Rs)

11.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 2725.00 2442.00  
High Price 2734.95 2469.20  
Low Price 2714.00 2411.05  
Last Price 2730.05 2419.20 -11.39
Volume 154 1,172 661.04
Simple Moving Averages
Days BSE NSE
30 2528.61 2536.35
50 2498.98 2506.47
150 2463.05 2470.35
200 2510.77 2516.99

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for GlaxoSmithKline

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
 Standalone Sep'17 Jun'17 Mar'17
Dec'16
Net Sales 836.26 586.79 763.43 689.29
Other Income 9.61 13.66 14.89 14.77
PBDIT 192.09 19.68 136.74 52.11
Net Profit 130.32 26.42 112.71 52.95

Annual Report

Download in PDF format 2016 |2015 |2013 |2012 |2011 |2010
Balance Sheet
Mar'17
(In Rs Cr)
Total Share Capital 84.70
Net Worth 2,028.21
Total Debt 0.99
Net Block 252.71
Investments 47.67
Total Assets 2,029.21
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 516.80 -0.77 728.45 433.15 123,996.24
Piramal Enter 2723.60 -3.46 3083.05 1443.90 46,999.29
Cipla 578.15 -2.13 663.00 504.15 46,530.79
Cadila Health 407.95 -1.68 558.00 342.00 41,763.58
Aurobindo Pharm 668.65 -1.27 808.95 504.00 39,175.03
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Mar' 17Dec' 16Sep' 16Jun' 16
Promoter75.0075.0075.0075.00
Public (FII + DII)25.0025.0025.0025.00
Others0.000.000.000.00
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
Dr. Annie Besant Road, ,
City
Mumbai
State
Maharashtra
Pin Code
400030
Tel. No.
022-24959595 022-24959415
Fax No.
022-24959494 022-24981526
Email:
REGISTRARS
Name
Karvy Computershare Private Ltd.
Address
Karvy Selenium Tower B Plot no. 31-32, Gachibowli Financial District Nanakramguda
City
Hyderabad - 500032
State
Telangana
Tel. No.
040-23001153
Fax No.
Email:
Internet
MANAGEMENT
Name
Designation
D S Parekh
Chairman
A Vaidheesh
Managing Director
A Aristidou
WholeTime Director & CFO
Subesh Williams
Non Executive Director
Marc Jones
Non Executive Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

Somi Conveyor Beltings Recommended on Oct 18th 2017

Recommended price 52.00  |  Peak from reco 75.00 45.49%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About GlaxoSmithKline

GlaxoSmithKline is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 20,491.35 crore.

The company management includes D S Parekh - Chairman, A Vaidheesh - Managing Director, A Aristidou - WholeTime Director & CFO, Subesh Williams - Non Executive Director, Marc Jones - Non Executive Director, R R Bajaaj - Director, A Bansal - Director, P V Bhide - Director, N Kaviratne - Director, R Krishnaswamy - Director, A N Roy - Director, D Sundaram - Director.

It is listed on the BSE with a BSE Code of 500660 and the NSE with an NSE Code of GLAXO.

Its Registered office is at Dr. Annie Besant Road, , Mumbai,Maharashtra - 400030.

Their Registrars are Karvy Computershare Private Ltd.

Quick Links for GlaxoSmithKline Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of GlaxoSmithKline